Pfizer announced that it will cut R&D jobs and abandon its research efforts in the areas of cardiovascular diseases, cholesterol management, osteoporosis, anemia and liver and muscle diseases. The company plans to refocus it drug development in five therapeutic areas including Alzheimer’s; diabetes; immune disorders and inflammation; cancer; pain; and mental illness, including schizophrenia. Also, the company will continue its work on anti-thrombotic
Breaking Up Is Hard to Do: Pfizer to Cut Jobs and Refocus Research Efforts
Posted by cliffmz 702 days ago (http://www.biojobblog.com)Who Voted for this Story
Comments